Clinical Trial Update: Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on pregnenolone for cognitive and negative symptoms in schizophrenia and schizoaffective disorder. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Pregnenolone (pregnenolone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-02-10